Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
M&A / Property

QScreen AI files patent application in U.S.

QAI · Price

Executive Summary

  • QScreen AI Inc. has filed a provisional patent application (No. 63/981,576) with the U.S. Patent and Trademark Office for a "System, Method and Robotic Platform for Quantum-Inspired Multi-Objective Optimization of Human-Governed Clinical Intake and Readiness Data Collection Under Operational Constraints."
  • The filing coincides with national media coverage on CBC News during Canada's Mexico trade mission, featuring an interview with COO Dr. Rahul Kushwah and participation by senior government officials, highlighting the strategic importance of the company's technology in cross-border innovation.
  • The patented technology utilizes quantum-inspired probabilistic algorithms on classical hardware to optimize workflow efficiency, risk detection, and stability in high-pressure environments such as military operations, public safety, and clinical settings.

Key Details

  • Patent Filing Details:
    • Type: Provisional Patent Application.
    • Application Number: 63/981,576.
    • Title: "System, Method and Robotic Platform for Quantum-Inspired Multi-Objective Optimization of Human-Governed Clinical Intake and Readiness Data Collection Under Operational Constraints."
  • Technological Breakthroughs:
    • Quantum-Inspired Probabilistic Optimization: A solver-agnostic engine modeling complex workflows as multiobjective energy minimization problems, using stochastic annealing for rapid convergence and surge adaptability.
    • Hybrid Governance: Enforces non-overridable safety triggers while allowing AI-driven adjustments, ensuring ethical compliance, auditability, and zero autonomous medical decisions.
    • Deployment Capabilities: Supports kiosks, tablets, Web portals, and physical robots, adapting in real-time to environmental factors for field deployments in defense, corrections, and large-scale events.
    • Surge-Responsive Metrics: Monitors operational metrics to recalibrate priorities during crises, minimizing false escalations through dual-trigger logic.
  • Strategic Context & Media Coverage:
    • CBC News Interview: Dr. Rahul Kushwah was interviewed on national broadcast during Canada's Mexico trade mission.
    • Government Engagement: The segment included Dominic LeBlanc (Minister responsible for Canada-U.S. trade) and Arturo Sarukhan (former ambassador of Mexico to the United States).
    • U.S. Engagement: Strategic engagement with Global Frontier Advisors LP, led by senior U.S. officials including the former director of the U.S. Department of Defence's Joint Artificial Intelligence Center.
  • Commercial Applications:
    • Target sectors include military health, occupational safety, clinical trials, enterprise wellness, and surge screening.
    • Focus on expanding into U.S. public safety markets and international partnerships.

Notable Quotes

  • "This U.S. patent filing represents a defining step in the evolution of our quantum-inspired optimization platform. We are addressing some of the most complex operational constraints in health care and defence, environments where efficiency, precision and readiness are mission-critical. As we actively engage in the Canada-Mexico trade mission and advance our collaboration with our partners in the U.S., we are positioning QScreen AI at the intersection of advanced computation and real-world deployment." — Dr. Rahul Kushwah, Chief Operating Officer
Read the original news release →

More from QScreen AI Inc